跳至主要内容
临床试验/IRCT20231026059867N1
IRCT20231026059867N1尚未招募2 期

Comparison of the effects of oral and injectable antiquaguane in the prevention of thromboembolic events in patients with gynecological cancers who underwent surgery.

Esfahan University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
Female

入选标准

  • People who have undergone surgery for gynecological cancers
  • Candidate to receive oral or injectable anticoagulants

排除标准

  • Lack of consent to continue participating in the study
  • History of thromboembolic events

研究者

相似试验